IKNA

Ikena Oncology (IKNA)

Ikena Oncology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IKNA

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/11	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2024/05/29	05:42	GlobeNewswire Inc.	UPDATE – Ikena Oncology Announces Strategic Update	NASDAQ:IKNA	Ikena Oncology Inc
2024/05/29	05:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2024/05/29	05:15	GlobeNewswire Inc.	Ikena Oncology Announces Strategic Update	NASDAQ:IKNA	Ikena Oncology Inc
2024/05/14	05:45	GlobeNewswire Inc.	Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update	NASDAQ:IKNA	Ikena Oncology Inc
2024/05/14	05:33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IKNA	Ikena Oncology Inc
2024/04/10	21:00	GlobeNewswire Inc.	Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	NASDAQ:IKNA	Ikena Oncology Inc
2024/03/12	21:00	GlobeNewswire Inc.	Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:IKNA	Ikena Oncology Inc
2024/03/06	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IKNA	Ikena Oncology Inc
2024/03/06	06:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IKNA	Ikena Oncology Inc
2024/02/27	22:00	GlobeNewswire Inc.	Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference	NASDAQ:IKNA	Ikena Oncology Inc
2024/02/22	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2024/02/22	06:15	GlobeNewswire Inc.	Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer	NASDAQ:IKNA	Ikena Oncology Inc
2024/02/03	07:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IKNA	Ikena Oncology Inc
2024/02/03	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IKNA	Ikena Oncology Inc
2024/01/19	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2024/01/19	06:05	GlobeNewswire Inc.	Ikena Oncology Outlines Key Priorities and Provides Corporate Updates	NASDAQ:IKNA	Ikena Oncology Inc
2023/11/09	21:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IKNA	Ikena Oncology Inc
2023/11/09	21:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2023/11/09	21:00	GlobeNewswire Inc.	Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	NASDAQ:IKNA	Ikena Oncology Inc
2023/11/07	22:00	GlobeNewswire Inc.	Ikena Oncology to Present at Multiple November 2023 Investor Conferences	NASDAQ:IKNA	Ikena Oncology Inc
2023/10/12	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IKNA	Ikena Oncology Inc
2023/09/26	05:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:IKNA	Ikena Oncology Inc
2023/09/16	05:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:IKNA	Ikena Oncology Inc
2023/09/13	05:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IKNA	Ikena Oncology Inc
2023/09/11	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IKNA	Ikena Oncology Inc
2023/09/05	21:00	GlobeNewswire Inc.	Ikena Oncology to Participate in September 2023 Investor Conferences	NASDAQ:IKNA	Ikena Oncology Inc
2023/08/19	05:03	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:IKNA	Ikena Oncology Inc
2023/08/19	05:02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IKNA	Ikena Oncology Inc
2023/08/10	21:00	GlobeNewswire Inc.	Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update	NASDAQ:IKNA	Ikena Oncology Inc